Cardiff Oncology, Inc. (CRDF) quarterly cash flow statement — complete operating, investing & financing history
Cardiff Oncology, Inc. (CRDF) cash flow statement — 18-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -11.77M | -12.29M | -5.97M | -10.83M | -8.33M | -12.79M | -10.27M | -10.46M | -9.23M | -7.74M | -7.14M | -7.96M | -7.13M | -8.66M | -9.39M | -7.49M | -6.7M | -10.25M | -7.39M | -5.46M |
| Operating CF Margin % | -11312.5% | -29970.73% | -2455.56% | -9028.33% | -6882.64% | -11737.61% | -6799.34% | -6336.97% | -5662.58% | -3775.61% | -4576.28% | -5643.26% | -6603.7% | -10432.53% | -7335.94% | -8049.46% | -7357.14% | -13850% | -5556.39% | -6354.65% |
| Operating CF Growth % | -41.27% | 3.96% | 41.88% | -3.62% | 9.77% | -65.3% | -43.82% | -31.41% | -29.42% | 10.61% | 23.97% | -6.29% | -6.53% | 15.51% | -27.06% | -36.98% | -55.66% | -74.18% | -44.22% | -55.02% |
| Net Income | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M | -13.43M | -11.79M | -11.86M | -11.78M | -10.01M | -9.34M | -9.73M | -11.15M | -11.22M | -8.7M | -8.57M | -10.44M | -10.99M | -9.44M | -6.91M |
| Depreciation & Amortization | -47K | 221K | 223K | 494K | 229K | 228K | 96K | 101K | 105K | 102K | 103K | 107K | 98K | 90K | 86K | 81K | 38K | 31K | 113K | 110K |
| Stock-Based Compensation | 920K | 1.66M | 1.26M | 1.38M | 1.68M | 1.36M | 1.2M | 1.25M | 1.18M | 1.12M | 909K | 955K | 1.58M | 1.06M | 1.01M | 1.04M | 1.05M | 1.15M | 990K | 940K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.04M | 0 | 0 | 0 | 0 | 0 | 0 | 442K | 0 |
| Other Non-Cash Items | 205K | -93K | -158K | -252K | -301K | -137K | -158K | -157K | -127K | -156K | -205K | 9.73M | -242K | -163K | -39K | 115K | 211K | 485K | 527K | 1.03M |
| Working Capital Changes | -3.61M | -1.73M | -77K | -1.2M | 4M | -816K | 378K | 202K | 1.39M | 1.2M | 1.39M | 1.02M | 2.58M | 1.57M | -1.75M | -148K | 2.44M | -924K | -20K | -631K |
| Change in Receivables | 2K | -9K | 72K | 272K | -121K | 368K | -154K | -167K | -58K | -105K | -90K | -37K | 515K | 95K | -236K | -99K | -104K | 88K | -215K | -86K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -3.48M | 0 | 940K | 0 | 4.27M | -1.04M | 0 | -1K | 673K | 1.42M | 0 | 135K | 0 | 203K | 1.35M | -42K | 0 | 0 | 719K | 291K |
| Cash from Investing | 12.27M | 3.26M | 10.75M | 10.16M | -4.98M | -14.58M | 4.51M | -9.43M | 14.02M | 4.64M | 13.56M | 3.82M | 11.48M | 7.33M | 7.02M | 5.16M | 7.61M | 18.36M | -8.79M | 8.05M |
| Capital Expenditures | -44K | 0 | 0 | -18K | -26K | 0 | 0 | 0 | 0 | -80K | -8K | -315K | -251K | -8K | -75K | -448K | -312K | -171K | -107K | -98K |
| CapEx % of Revenue | 42.31% | - | - | 15% | 21.49% | - | - | - | - | 39.02% | 5.13% | 223.4% | 232.41% | 9.64% | 58.59% | 481.72% | 342.86% | 231.08% | 80.45% | 113.95% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 315K | 0 | -7.34M | -7.09M | 0 | 0 | 0 | -98K | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -744K | 0 | 0 | -902K | 0 | 0 | 0 | 0 | 0 | -315K | 0 | 7.34M | 7.09M | 43K | 71K | 0 | 98K | 0 |
| Cash from Financing | 149K | 105K | 2.55M | 25K | 0 | 3K | 44.19M | 7.43M | 2.06M | 107K | 0 | -6K | 0 | 0 | 0 | 75K | 0 | 0 | 14.96M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 213K | 105K | 2.55M | 0 | 0 | 3K | 44.17M | 7.43M | 2.06M | 107K | 0 | 0 | 0 | 0 | 0 | 75K | 0 | 0 | 14.96M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6K | 0 | 0 | 0 | -6K | 0 | 0 | -414K | 0 | 0 | 0 | -24K | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -64K | 0 | 0 | 25K | 0 | 0 | 13K | 6K | 0 | 0 | 0 | 0 | 0 | 0 | 414K | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 653K | -8.93M | 7.33M | -649K | -13.31M | -27.38M | 38.43M | -12.46M | 6.84M | -3M | 6.42M | -4.14M | 4.35M | -1.33M | -2.37M | -2.25M | 913K | 8.11M | -1.22M | 2.58M |
| Free Cash Flow | -11.81M | -12.29M | -5.97M | -10.85M | -8.35M | -12.79M | -10.27M | -10.46M | -9.23M | -7.82M | -7.15M | -8.27M | -7.38M | -8.67M | -9.46M | -7.93M | -7.01M | -10.42M | -7.5M | -5.56M |
| FCF Margin % | -11354.81% | -29970.73% | -2455.56% | -9043.33% | -6904.13% | -11737.61% | -6799.34% | -6336.97% | -5662.58% | -3814.63% | -4581.41% | -5866.67% | -6836.11% | -10442.17% | -7394.53% | -8531.18% | -7700% | -14081.08% | -5636.84% | -6468.6% |
| FCF Growth % | -41.36% | 3.96% | 41.88% | -3.79% | 9.49% | -63.61% | -43.65% | -26.4% | -25.02% | 9.77% | 24.49% | -4.26% | -5.37% | 16.82% | -26.25% | -42.62% | -62.92% | -77.09% | -44.67% | -51.21% |
| FCF per Share | -0.17 | -0.18 | -0.09 | -0.16 | -0.13 | -0.27 | -0.22 | -0.22 | -0.21 | -0.18 | -0.16 | -0.19 | -0.17 | -0.19 | -0.21 | -0.18 | -0.16 | -0.24 | -0.18 | -0.14 |
| FCF Conversion (FCF/Net Income) | 1.27x | 1.00x | 0.83x | 0.96x | 0.60x | 0.95x | 0.87x | 0.88x | 0.78x | 0.77x | 0.76x | 0.82x | 0.64x | 0.77x | 1.08x | 0.87x | 0.64x | 0.93x | 0.78x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 1K | 0 | 0 | 1K | 0 | 0 |